TCGA, ISB Researchers Identify Potential Drug Targets for Leading Form of Deadly Liver Cancer
![](https://isbscience.org/wp-content/themes/isb-main/images/ISB.png)
![](https://isbscience.org/wp-content/uploads/data3.jpg)
June 19, 2017
Researchers in ISB’s Shmulevich Lab and their colleagues in The Cancer Genome Atlas Research Network performed the first large-scale, multi-platform analysis of hepatocellular carcinoma, the predominant form of liver cancer. Study was published on June 15, 2017, in the journal Cell.
3 Bullets:
- Liver cancer is the second most common cause of death from cancer worldwide.
- ISB researchers and colleagues from The Cancer Genome Atlas Research Network performed the first large-scale, multi-platform analysis of hepatocellular carcinoma, the predominant form of liver cancer.
- Such integrated analyses enabled the identification of potential therapeutic targets and facilitated biological insights that would not have been possible otherwise.